{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:22:33Z","timestamp":1788524553702,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To establish the risk scoring model for HIV-negative neurosyphilis (NS) patients and to optimize the lumbar puncture strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2016 to 2021, clinical information on 319 syphilis patients was gathered. Multivariate logistic regression was used to examine the independent risk factors in NS patients who tested negative for human immunodeficiency virus (HIV). Receiver operating characteristic curves (ROC) were used to assess the risk scoring model\u2019s capacity for identification. According to scoring model, the timing of lumbar puncture was suggested.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were statistically significant differences between HIV-negative NS and non-neurosyphilis (NNS) patients in the following factors. These included age, gender, neuropsychiatric symptoms (including visual abnormalities, hearing abnormalities, memory abnormalities, mental abnormalities, paresthesia, seizures, headache, dizziness), serum toluidine red unheated serum test (TRUST), cerebrospinal fluid Treponema pallidum particle agglutination test (CSF-TPPA), cerebrospinal fluid white blood cell count (CSF-WBC), and cerebrospinal fluid protein quantification (CSF-Pro) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Logistic regression analysis of HIV-negative NS patients risk factors showed that age, gender, and serum TRUST were independent risk factors for HIV-negative NS (<jats:italic>P<\/jats:italic>\u2009=\u20090.000). The total risk score (\u2212\u20091\u2009~\u200911 points) was obtained by adding the weight scores of each risk factor. And the predicted probability of NS in HIV-negative syphilis patients (1.6\u2009~\u200986.6%) was calculated under the corresponding rating. ROC calculation results showed that the score had good discrimination value for HIV-negative NS and NNS: area under the curve (AUC) was 0.80, the standard error was 0.026 and 95% CI was 74.9\u201385.1% (<jats:italic>P<\/jats:italic>\u2009=\u20090.000).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The risk scoring model in this study can classify the risk of neurosyphilis in syphilis patients, optimize the lumbar puncture strategy to a certain extent, and provide ideas for the clinical diagnosis and treatment of HIV-negative neurosyphilis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01177-5","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:01:59Z","timestamp":1688004119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Establishment of HIV-negative neurosyphilis risk score model based on logistic regression"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0750-9630","authenticated-orcid":false,"given":"Yu","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-3126","authenticated-orcid":false,"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-0120","authenticated-orcid":false,"given":"Raqib","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5296-7665","authenticated-orcid":false,"given":"Donghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"1","key":"1177_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/CMR.19.1.29-49.2006","volume":"19","author":"RE Lafond","year":"2006","unstructured":"Lafond RE, Lukehart SA. Biological basis for syphilis. Clin Microbiol Rev. 2006;19(1):29\u201349. https:\/\/doi.org\/10.1128\/CMR.19.1.29-49.2006.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1177_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/01.olq.0000162359.75509.9c","volume":"32","author":"HW Chesson","year":"2005","unstructured":"Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis. 2005;32(5):265\u20139. https:\/\/doi.org\/10.1097\/01.olq.0000162359.75509.9c.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"1177_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0956462415590710","volume":"27","author":"F Drago","year":"2016","unstructured":"Drago F, Javor S, Parodi A. Neurosyphilis: from infection to autoinflammation? Int J STD AIDS. 2016;27(4):327\u20138. https:\/\/doi.org\/10.1177\/0956462415590710.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"1177_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12879-018-3062-4","volume":"18","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Weng R, Zhang Y, et al. The performance of rapid plasma reagin (RPR) titer in HIV-negative general paresis after neurosyphilis therapy. BMC Infect Dis. 2018;18(1):144. https:\/\/doi.org\/10.1186\/s12879-018-3062-4. (Published 2018 Apr 2).","journal-title":"BMC Infect Dis"},{"issue":"6 Neuroinfectio","key":"1177_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1212\/CON.0000000000000250","volume":"21","author":"CM Marra","year":"2015","unstructured":"Marra CM. Neurosyphilis. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1714\u201328. https:\/\/doi.org\/10.1212\/CON.0000000000000250.","journal-title":"Continuum (Minneap Minn)"},{"issue":"11","key":"1177_CR6","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1001\/jama.290.11.1510","volume":"290","author":"MR Golden","year":"2003","unstructured":"Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003;290(11):1510\u20134. https:\/\/doi.org\/10.1001\/jama.290.11.1510.","journal-title":"JAMA"},{"issue":"2","key":"1177_CR7","doi-asserted-by":"publisher","first-page":"e002204","DOI":"10.1136\/bmjopen-2012-002204","volume":"3","author":"W Gu","year":"2013","unstructured":"Gu W, Yang Y, Wu L, Yang S, Ng LK. Comparing the performance characteristics of CSF-TRUST and CSF-VDRL for syphilis: a cross-sectional study. BMJ Open. 2013;3(2):e002204. https:\/\/doi.org\/10.1136\/bmjopen-2012-002204. (Published 2013 Feb 21).","journal-title":"BMJ Open"},{"issue":"1","key":"1177_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/s12879-019-4582-2","volume":"19","author":"Y Lu","year":"2019","unstructured":"Lu Y, Ke W, Yang L, et al. Clinical prediction and diagnosis of neurosyphilis in HIV-negative patients: a case-control study. BMC Infect Dis. 2019;19(1):1017. https:\/\/doi.org\/10.1186\/s12879-019-4582-2. (Published 2019 Dec 2).","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1177_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jdv.16946","volume":"35","author":"M Janier","year":"2021","unstructured":"Janier M, Unemo M, Dupin N, Tiplica GS, Poto\u010dnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35(3):574\u201388. https:\/\/doi.org\/10.1111\/jdv.16946.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1177_CR10","unstructured":"CAO Q. Analysis of risk factors of common chronic diseases and establishment of risk assessment model [D]. Shanxi Medical University. 2018."},{"issue":"1","key":"1177_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12879-017-2339-3","volume":"17","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Tong ML, Liu LL, et al. Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: an observational study [published correction appears in BMC Infect Dis. 2017 May 22;17 (1):357]. BMC Infect Dis. 2017;17(1):310. https:\/\/doi.org\/10.1186\/s12879-017-2339-3. (Published 2017 Apr 26).","journal-title":"BMC Infect Dis"},{"issue":"3","key":"1177_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/OLQ.0b013e3181f42093","volume":"38","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Chen X, Ma X, Yang Y, Peng F, Hu X. The usefulness of toluidine red unheated serum test in the diagnosis of HIV-negative neurosyphilis. Sex Transm Dis. 2011;38(3):244\u20135. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181f42093.","journal-title":"Sex Transm Dis"},{"issue":"45","key":"1177_CR13","doi-asserted-by":"publisher","first-page":"e2023","DOI":"10.1097\/MD.0000000000002023","volume":"94","author":"JJ Sun","year":"2015","unstructured":"Sun JJ, Wang ZY, Shen JY, et al. Serum TRSUT Titer \u2265\u00a01:16 is a predictor for neurosyphilis among HIV-infected patients with concurrent syphilis and no neurological symptoms. Medicine (Baltimore). 2015;94(45):e2023. https:\/\/doi.org\/10.1097\/MD.0000000000002023.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1177_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1086\/381227","volume":"189","author":"CM Marra","year":"2004","unstructured":"Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369\u201376. https:\/\/doi.org\/10.1086\/381227.","journal-title":"J Infect Dis"},{"issue":"4","key":"1177_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/jdv.13514","volume":"30","author":"M Shi","year":"2016","unstructured":"Shi M, Peng RR, Gao Z, et al. Risk profiles of neurosyphilis in HIV-negative patients with primary, secondary and latent syphilis: implications for clinical intervention. J Eur Acad Dermatol Venereol. 2016;30(4):659\u201366. https:\/\/doi.org\/10.1111\/jdv.13514.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1177_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/0956462420965850","volume":"32","author":"W Weng","year":"2021","unstructured":"Weng W, Hou J, Song B, Zhang M, Zhang T, Gao Y. Identification of the factors associated with post-treatment asymptomatic neurosyphilis in HIV-negative patients with serological non-response syphilis: a retrospective study. Int J STD AIDS. 2021;32(4):331\u20135. https:\/\/doi.org\/10.1177\/0956462420965850.","journal-title":"Int J STD AIDS"},{"issue":"3","key":"1177_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/practneurol-2017-001754","volume":"18","author":"E Hobbs","year":"2018","unstructured":"Hobbs E, Vera JH, Marks M, Barritt AW, Ridha BH, Lawrence D. Neurosyphilis in patients with HIV. Pract Neurol. 2018;18(3):211\u20138. https:\/\/doi.org\/10.1136\/practneurol-2017-001754.","journal-title":"Pract Neurol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01177-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:03:09Z","timestamp":1688004189000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01177-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. (This paper does not have any detailed information about the research object, only the total data after statistical induction.)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Each contributor to this study agrees to contribute, has no objection to the ranking of authors, and has no conflict of interest with the results of the research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}